Cannabidiol
Back to searchMolecule Structure
Scientific Name
Cannabidiol
Description of the Drug
Cannabidiol is an active cannabinoid used as an adjunctive treatment for the management of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome and symptomatic relief of moderate to severe neuropathic pain or other painful conditions, like cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09061
http://www.drugbank.ca/drugs/DB09061
Brand Name(s)
Epidiolex
Company Owner(s)
Gw Research Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cannabinoid CB1 receptor | SINGLE PROTEIN | NEGATIVE ALLOSTERIC MODULATOR | CHEMBL218 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL119679 | |
DrugBank | DB09061 | |
PubChem: Thomson Pharma | 14899058 | 14825860 |
PubChem | 644019 | |
NMRShiftDB | 60019489 | |
Nikkaji | J10.356J | |
PDBe | P0T | |
BindingDB | 50121429 | 50318484 |
LipidMaps | LMPK13120005 | |
DrugCentral | 5288 | |
Metabolights | MTBLC69478 | |
Brenda | 62441 | |
ChemicalBook | CB7673434 | |
Guide to Pharmacology | 4150 | |
rxnorm | CANNABIDIOL | EPIDIOLEX |
PubChem: Drugs of the Future | 12012585 | |
ChEBI | 69478 | |
ZINC | ZINC000004097406 |